Welcome to LookChem.com Sign In|Join Free
  • or
Benzenesulfonamide, 4-isothiocyanato-N-2-quinoxalinyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

681235-15-4

Post Buying Request

681235-15-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

681235-15-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 681235-15-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,1,2,3 and 5 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 681235-15:
(8*6)+(7*8)+(6*1)+(5*2)+(4*3)+(3*5)+(2*1)+(1*5)=154
154 % 10 = 4
So 681235-15-4 is a valid CAS Registry Number.

681235-15-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-isothiocyanato-N-quinoxalin-2-ylbenzenesulfonamide

1.2 Other means of identification

Product number -
Other names Benzenesulfonamide,4-isothiocyanato-N-2-quinoxalinyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:681235-15-4 SDS

681235-15-4Downstream Products

681235-15-4Relevant academic research and scientific papers

Synthesis, in-vitro anticancer screening and radiosensitizing evaluation of some new N-(quinoxalin-2-yl)benzenesulfonamide derivatives

Ghorab,Ragab,Heiba,El-Gazzar,El-Gazzar

, p. 46 - 52 (2012)

The objective of this work is to synthesize and investigate the anticancer activity of a new series of sulfaquinoxaline derivatives by incorporating biologically active moieties (thiourethane, thiazole, imidazole, imidazopyrimidine, imidazopyrimido-pyrimidine, thienopyrimidine, benzopyrimidinone, benzothiazole, thiazole and pyridine moieties). All the newly synthesized compounds were evaluated for their in-vitro anticancer activity against human liver cell line (HEPG2). All the tested compounds showed comparable activity to that of the reference drug 5-fluorouracil (IC 50=40 M), and the most potent compounds were found to be compounds 4 and 17 (IC50=4.29 and 11.27 M, respectively). On the other hand, the most potent compounds 4 and 17 were evaluated as radiosensitizing agents. Georg Thieme Verlag KG Stuttgart · New York.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 681235-15-4